Drug information provided by: Merative, Micromedex®
Omidubicel-onlv injection is used to reduce the risk of infection and white blood cell (eg, neutrophil) recovery time in patients with blood cancer who have a planned umbilical cord blood transplantation after receiving high-dose chemotherapy (myeloablative conditioning).
This medicine is to be given only by or under the immediate supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.